Publications by authors named "Adela Canete"

57Publications

Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition.

JCO Precis Oncol 2020 20;4. Epub 2020 May 20.

Department of Hematology and Oncology, Hospital for Sick Children, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.19.00298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446502PMC
May 2020

Metabolomic profiling in neuroblastoma.

Pediatr Blood Cancer 2020 03 4;67(3):e28113. Epub 2019 Dec 4.

Pediatric Oncology Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.28113DOI Listing
March 2020

Review: Ewing Sarcoma Predisposition.

Pathol Oncol Res 2020 Oct 26;26(4):2057-2066. Epub 2019 Oct 26.

Pediatric Oncology and Hematology Unit, La Fe Hospital, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12253-019-00765-3DOI Listing
October 2020

Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma.

BMC Cancer 2019 May 22;19(1):479. Epub 2019 May 22.

Pathology Department, Medical School, University of Valencia-INCLIVA, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5693-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532218PMC
May 2019

High Oct4 expression: implications in the pathogenesis of neuroblastic tumours.

BMC Cancer 2019 Jan 3;19(1). Epub 2019 Jan 3.

Pathology Department, Medical School, University of Valencia-INCLIVA, Av. Blasco Ibáñez, 15, 46010, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-5219-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318846PMC
January 2019

Lymph microvascularization as a prognostic indicator in neuroblastoma.

Oncotarget 2018 May 25;9(40):26157-26170. Epub 2018 May 25.

Pathology Department, Medical School, University of Valencia-INCLIVA, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25457DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995242PMC
May 2018

[Li-Fraumeni: Will the detection in families increase the survival of its members?]

An Pediatr (Barc) 2019 Jan 17;90(1):54-55. Epub 2018 Apr 17.

Sección Oncología Infantil, Hospital Universitario y Politécnico la Fe, Valencia, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anpedi.2018.03.009DOI Listing
January 2019

Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma.

J Clin Oncol 2018 04 7;36(10):951-958. Epub 2018 Feb 7.

Jacques Grill, Marie-Cécile Le Deley, and Gilles Vassal, Institut Gustave-Roussy, Villejuif; Marie-Cécile Le Deley, Paris-Saclay and Paris-Sud Universities, CESP, Institut National de la Santé et de la Recherche Médicale, Orsay; Pascale Varlet, Sainte-Anne Hospital, Paris, France; Maura Massimino, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan; Felice Giangaspero, Sapienza University, Rome; Felice Giangaspero, IRCCS Neuromed, Pozzilli, Italy; Eric Bouffet, Hospital for Sick Children, Toronto, Ontario, Canada; Amedeo A. Azizi, Medical University of Vienna, Vienna, Austria; Geoffrey McCowage, Australasian Children's Cancer Trials, Clayton, Victoria, Australia; Adela Cañete, Hospital La Fe, Valencia, Spain; Frank Saran, The Royal Marsden Hospital; Chris Jones, The Institute of Cancer Research; Darren Hargrave, Great Ormond Street Hospital, London; Paul S. Morgan and Tim Jaspan, Nottingham University Hospitals, Queen's Medical Centre, Nottingham, United Kingdom; Helen Smith, Josep Garcia, Markus C. Elze, and Lauren Abrey, F. Hoffmann-La Roche Ltd, Basel, Switzerland; and Raphaël F. Rousseau, Gritstone Oncology, Emeryville, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.0611DOI Listing
April 2018

Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.

Clin Cancer Res 2017 Nov 22;23(22):6875-6887. Epub 2017 Aug 22.

Laboratory of Cellular and Molecular Biology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-0593DOI Listing
November 2017

TIAM1 variants improve clinical outcome in neuroblastoma.

Oncotarget 2017 Jul;8(28):45286-45297

Laboratory of Cellular and Molecular Biology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.16787DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542186PMC
July 2017

[Early clinical trials in paediatric oncology in Spain: a nationwide perspective].

An Pediatr (Barc) 2017 Sep 6;87(3):155-163. Epub 2017 Mar 6.

Unidad de Investigación Clínica CNIO-HNJ, Servicio de Hematología, Oncología y Trasplante de Progenitores Hematopoyéticos, Hospital Infantil Universitario Niño Jesús, Madrid, España; Instituto de Investigación La Princesa, Madrid, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anpedi.2016.07.007DOI Listing
September 2017

Advances in emerging drugs for the treatment of neuroblastoma.

Expert Opin Emerg Drugs 2017 03 22;22(1):63-75. Epub 2017 Feb 22.

a Unidad de Oncologia Pediatrica, Hospital Universitario La Fe , Valencia , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728214.2017.1294159DOI Listing
March 2017

[The new challenge in oncology: Next-generation sequencing and its application in precision medicine].

An Pediatr (Barc) 2016 Nov 24;85(5):273.e1-273.e7. Epub 2016 Jun 24.

Investigación Clínica y Traslacional en Cáncer, Instituto de Investigación Sanitaria La Fe, Valencia, España. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anpedi.2016.05.006DOI Listing
November 2016

Immunoproteomic studies on paediatric opsoclonus-myoclonus associated with neuroblastoma.

J Neuroimmunol 2016 08 25;297:98-102. Epub 2016 May 25.

Laboratorio de Neurología, Instituto de Investigación Sanitaria La Fe, Hospital Universitario y Politécnico La Fe, CIBERER, Valencia, Spain; Servicio de Neurología, Hospital Universitario y Politécnico La Fe, Valencia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2016.05.015DOI Listing
August 2016

miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.

Mol Oncol 2016 08 23;10(7):1043-53. Epub 2016 Apr 23.

Clinical and Translational Research in Cancer, Instituto de Investigación Sanitaria La Fe, Spain; Laboratory of Cellular and Molecular Biology, Instituto de Investigación Sanitaria La Fe, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2016.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423177PMC
August 2016

Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.

J Pediatr Hematol Oncol 2016 Apr;38(3):176-81

*Pediatric Oncology Unit †Pediatric Orthopedics Unit ‡Medical Oncology Department §Pediatric Radiology Unit ∥Pediatric Surgery Department, Hospital La Fe ¶Cancer Clinical and Translational Research Group, Health Research Institute La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000546DOI Listing
April 2016

TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients.

J Cancer Res Clin Oncol 2016 Mar 24;142(3):573-80. Epub 2015 Oct 24.

Unidad de Oncología Pediátrica, Hospital La Fe, Avda. Fernando Abril Martorell, 106, 46026, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-015-2054-7DOI Listing
March 2016

Two independent epigenetic biomarkers predict survival in neuroblastoma.

Clin Epigenetics 2015 27;7:16. Epub 2015 Feb 27.

Pediatric Oncology Unit, Hospital Universitari i Politècnic La Fe, Avda Fernando Abril Martorell, Valencia, 46026 Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13148-015-0054-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357365PMC
March 2015

Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience.

J Pediatr Hematol Oncol 2015 Jul;37(5):e272-7

*Pediatric Oncology Unit ‡Medical Oncology Department §Pediatric Orthopedics Unit ∥Orthopedics Department ¶Pediatric Radiology Unit #Pathology Department †Cancer Clinical and Translational Research Group, Health Research Institute La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000270DOI Listing
July 2015

Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma.

Pediatr Res 2014 Feb 11;75(2):302-14. Epub 2013 Nov 11.

Pathology Department, Medical School, University of Valencia, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/pr.2013.217DOI Listing
February 2014

Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor.

PLoS One 2013 7;8(10):e76761. Epub 2013 Oct 7.

Laboratory of Molecular Endocrinology, Centro de Investigación Príncipe Felipe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076761PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792090PMC
August 2014

New prognostic markers in neuroblastoma.

Expert Opin Med Diagn 2012 Nov 11;6(6):555-67. Epub 2012 Jul 11.

Department of Pathology, Medical School, University of Valencia , Avda. Blasco Ibañez 15 Valencia 46010 , Spain +34 96 3864146 ; +34 96 3864173 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17530059.2012.704018DOI Listing
November 2012

Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.

J Cancer Res Clin Oncol 2011 Aug 25;137(8):1263-72. Epub 2011 Jun 25.

Unidad de Oncología Pediátrica, Hospital Universitario y Politécnico La Fe, Bulevar Sur S/N, 46026 Valencia, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-011-0997-x
Publisher Site
http://dx.doi.org/10.1007/s00432-011-0997-xDOI Listing
August 2011

Prognostic value of partial genetic instability in neuroblastoma with ≤50% neuroblastic cell content.

Histopathology 2011 Jul 13;59(1):22-30. Epub 2011 Jun 13.

Department of Pathology, Medical School, University of Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2011.03899.xDOI Listing
July 2011

Treatment of high-risk neuroblastoma with anti-GD2 antibodies.

Clin Transl Oncol 2010 Dec;12(12):788-93

Grupo de Neuroblastoma SEHOP, Unidad de Oncología Pediátrica, Hospital Universitario La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-010-0600-yDOI Listing
December 2010

Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease.

Mol Carcinog 2011 Mar 23;50(3):153-62. Epub 2010 Nov 23.

Unidad de Genética y Diagnóstico Prenatal, Hospital Universitario La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.20700DOI Listing
March 2011

Retained intravascular fragments after removal of indwelling central venous catheters: a single institution experience.

J Pediatr Surg 2010 Jul;45(7):1491-5

Paediatric Oncology Unit, Hospital Infantil Universitario La Fe, Avenida de Campanar 21, 46009 Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpedsurg.2010.02.001DOI Listing
July 2010

Neuroblastoma in adolescents: genetic and clinical characterisation.

Clin Transl Oncol 2010 Jan;12(1):49-54

Unidad de Oncología Pediátrica, Hospital Universitario La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-010-0466-zDOI Listing
January 2010

Analysis of biological prognostic factors using tissue microarrays in neuroblastic tumors.

Pediatr Blood Cancer 2009 Feb;52(2):209-14

Department of Pathology, Medical School, University of Valencia, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21833DOI Listing
February 2009

MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.

J Cancer Res Clin Oncol 2009 Apr 27;135(4):523-31. Epub 2008 Sep 27.

Unidad de Genética y Diagnóstico Prenatal, Hospital Universitario La Fe, Av/Campanar no. 21, 46009, Valencia, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-008-0484-1
Publisher Site
http://dx.doi.org/10.1007/s00432-008-0484-1DOI Listing
April 2009

[Neuroblastoma].

Clin Transl Oncol 2005 Apr;7(3):133-45

Pediatric Oncology Unit, Hospital Infantil La Fe, Avda. Campanar 21, 48009 Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02708748DOI Listing
April 2005

A comparison of current neuroblastoma chemotherapeutics.

Expert Opin Pharmacother 2004 Jan;5(1):71-80

Pediatric Oncology Unit, Hospital Infantil Universitario La Fe, Avda Campanar 21, 46009 Valencia, Spain.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14656566.5.1.71
Publisher Site
http://dx.doi.org/10.1517/14656566.5.1.71DOI Listing
January 2004

MYCN gain and MYCN amplification in a stage 4S neuroblastoma.

Cancer Genet Cytogenet 2003 Jan;140(2):157-61

Deparment of Pathology, Medical School, University of Valencia, Avda. Blasco Ibañez, 17,46010 Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-4608(02)00677-5DOI Listing
January 2003